Literature DB >> 25548459

Molecular Characterization of G6PD Deficient Variants in Nineveh Province, Northwestern Iraq.

Muna A Kashmoola1, Adil A Eissa2, Dahlia T Al-Takay1, Nasir A S Al-Allawi2.   

Abstract

Glucose-6-phosphate dehydrogenase (G6PD) deficiency considered to be the commonest inherited enzymopathies disorders worldwide including Iraq. Studies have addressed its prevalence and molecular characterization in several parts of the country, but no data were available from Nineveh province, northwestern-Iraq regarding molecular basis of this inherited enzymopathy. To determine the molecular basis of G6PD deficient variants in Nineveh province. A total of 61 G6PD deficient male individuals from Nineveh province were enrolled in this study. DNA from all enrolled individuals were extracted and analyzed for four deficient molecular variants using a polymerase chain reaction-restriction fragment polymorphism method. These deficient variants were G6PD-Mediterranean (563 C→T), G6PD-Chatham (1003 G→A), G6PD-A-(202 G→A) and G6PD-Cosenza (1376 G→C). Also enrolled individuals were screened for silent 1311 (C→T) mutation. It was found that 46 (75.41 %) were G6PD-Mediterranean, 1(1.64 %) were G6PD-Chatham, another 1(1.64 %) were G6PD-A-, and 13 (21.31 %) were remained uncharacterized. Also all G6PD-Mediterranean as well as one uncharacterized individuals were carriers of silent 1311 (C→T) mutation. This study documented that G6PD-Mediterranean constitute the bulk of G6PD deficient variants in this province and G6PD-Chatham and A- were encountered less frequently. Also that silent 1311 (C→T) mutation were common among G6PD-Mediterranean deficient variants individuals.

Entities:  

Keywords:  G6PD; G6PD-Mediterranean; Iraq; Nineveh

Year:  2014        PMID: 25548459      PMCID: PMC4275522          DOI: 10.1007/s12288-014-0368-2

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN: 0971-4502            Impact factor:   0.900


  18 in total

1.  Molecular characterization of glucose-6-phosphate dehydrogenase deficiency in Turkey.

Authors:  R Oner; F Gümrük; C Acar; C Oner; A Gürgey; C Altay
Journal:  Haematologica       Date:  2000-03       Impact factor: 9.941

2.  Molecular identification of G6PD Chatham (G1003A) in Khuzestan province of Iran.

Authors:  Maryam Ghaderi Gandomani; Saeid Reza Khatami; Seyed Reza Kazemi Nezhad; Setareh Daneshmand; Amir Mashayekhi
Journal:  J Genet       Date:  2011-04       Impact factor: 1.166

3.  Glucose-6-phosphate dehydrogenase deficiency in Kuwait, Syria, Egypt, Iran, Jordan and Lebanon.

Authors:  E A Usanga; R Ameen
Journal:  Hum Hered       Date:  2000 May-Jun       Impact factor: 0.444

Review 4.  G6PD deficiency.

Authors:  E Beutler
Journal:  Blood       Date:  1994-12-01       Impact factor: 22.113

Review 5.  G6PD: population genetics and clinical manifestations.

Authors:  E Beutler
Journal:  Blood Rev       Date:  1996-03       Impact factor: 8.250

6.  Three major glucose-6-phosphate dehydrogenase-deficient polymorphic variants identified in Mazandaran state of Iran.

Authors:  Seyed A Mesbah-Namin; Mohammad H Sanati; Alireza Mowjoodi; Philip J Mason; Tom J Vulliamy; Mohammad R Noori-Daloii
Journal:  Br J Haematol       Date:  2002-06       Impact factor: 6.998

7.  Prevalence and molecular characterization of Glucose-6-Phosphate dehydrogenase deficient variants among the Kurdish population of Northern Iraq.

Authors:  Nasir Al-Allawi; Adil A Eissa; Jaladet Ms Jubrael; Shakir Ar Jamal; Hanan Hamamy
Journal:  BMC Blood Disord       Date:  2010-07-05

8.  Glucose-6-phosphate dehydrogenase deficiency among ethnic groups in Iraq.

Authors:  L Amin-Zaki; S T el-Din; K Kubba
Journal:  Bull World Health Organ       Date:  1972       Impact factor: 9.408

9.  G6PD Mediterranean accounts for the high prevalence of G6PD deficiency in Kurdish Jews.

Authors:  A Oppenheim; C L Jury; D Rund; T J Vulliamy; L Luzzatto
Journal:  Hum Genet       Date:  1993-04       Impact factor: 4.132

10.  Origin and spread of the glucose-6-phosphate dehydrogenase variant (G6PD-Mediterranean) in the Middle East.

Authors:  B Kurdi-Haidar; P J Mason; A Berrebi; G Ankra-Badu; A al-Ali; A Oppenheim; L Luzzatto
Journal:  Am J Hum Genet       Date:  1990-12       Impact factor: 11.025

View more
  4 in total

1.  Molecular Characterization and Genotype-Phenotype Correlation of G6PD Mutations in Five Ethnicities of Northern Vietnam.

Authors:  Thi Thao Ngo; Thinh Huy Tran; Thanh Dat Ta; Thi Phuong Le; Phuoc Dung Nguyen; Mai Anh Tran; The-Hung Bui; Thanh Van Ta; Van Khanh Tran
Journal:  Anemia       Date:  2022-07-05

2.  COVID-19 Disease and Associated Thrombocytopenia: Pathogenesis and a Clue to the Etiology.

Authors:  Adil Abozaid Eissa
Journal:  Diagnostics (Basel)       Date:  2022-04-20

3.  Impact Of TP53 Gene Promoter Methylation On Chronic Lymphocytic Leukemia Pathogenesis And Progression.

Authors:  Waleed Haji Saeed; Adil Abozaid Eissa; Adnan Anwar Al-Doski
Journal:  J Blood Med       Date:  2019-11-25

4.  G6PD Deficiency and Hemoglobinopathies: Molecular Epidemiological Characteristics and Healthy Effects on Malaria Endemic Bioko Island, Equatorial Guinea.

Authors:  Min Lin; Li Ye Yang; Dong De Xie; Jiang Tao Chen; Santiago-m Monte Nguba; Carlos Sala Ehapo; Xiao Fen Zhan; Juan Urbano Monsuy Eyi; Rocio Apicante Matesa; Maximo Miko Ondo Obono; Hui Yang; Hui Tian Yang; Ji Dong Cheng
Journal:  PLoS One       Date:  2015-04-27       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.